These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 2183224)

  • 21. Genetic and pharmacological suppression of oncogenic mutations in ras genes of yeast and humans.
    Schafer WR; Kim R; Sterne R; Thorner J; Kim SH; Rine J
    Science; 1989 Jul; 245(4916):379-85. PubMed ID: 2569235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line.
    Ghosh PM; Ghosh-Choudhury N; Moyer ML; Mott GE; Thomas CA; Foster BA; Greenberg NM; Kreisberg JI
    Oncogene; 1999 Jul; 18(28):4120-30. PubMed ID: 10435593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship among methylation, isoprenylation, and GTP binding in 21- to 23-kDa proteins of neuroblastoma.
    Haklai R; Kloog Y
    Cell Mol Neurobiol; 1991 Aug; 11(4):415-33. PubMed ID: 1751964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prenyl group identification of rap2 proteins: a ras superfamily member other than ras that is farnesylated.
    Farrell FX; Yamamoto K; Lapetina EG
    Biochem J; 1993 Jan; 289 ( Pt 2)(Pt 2):349-55. PubMed ID: 8424780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The carboxyl-terminal CXXX sequence of Gi alpha, but not Rab5 or Rab11, supports Ras processing and transforming activity.
    Cox AD; Graham SM; Solski PA; Buss JE; Der CJ
    J Biol Chem; 1993 Jun; 268(16):11548-52. PubMed ID: 8505289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isoprenoid modification and plasma membrane association: critical factors for ras oncogenicity.
    Der CJ; Cox AD
    Cancer Cells; 1991 Sep; 3(9):331-40. PubMed ID: 1751286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isoprenoid modification permits 2',3'-cyclic nucleotide 3'-phosphodiesterase to bind to membranes.
    Braun PE; De Angelis D; Shtybel WW; Bernier L
    J Neurosci Res; 1991 Nov; 30(3):540-4. PubMed ID: 1666129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of recombinant human Kirsten-ras (4B) p21 produced at high levels in Escherichia coli and insect baculovirus expression systems.
    Lowe PN; Page MJ; Bradley S; Rhodes S; Sydenham M; Paterson H; Skinner RH
    J Biol Chem; 1991 Jan; 266(3):1672-8. PubMed ID: 1899093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of a human c-K-ras oncogene.
    Yamamoto F; Perucho M
    Nucleic Acids Res; 1984 Dec; 12(23):8873-85. PubMed ID: 6096811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isoprenylation of the low molecular mass GTP-binding proteins rac 1 and rac 2: possible role in membrane localization.
    Didsbury JR; Uhing RJ; Snyderman R
    Biochem Biophys Res Commun; 1990 Sep; 171(2):804-12. PubMed ID: 2119580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The COOH-terminal domain of the Rap1A (Krev-1) protein is isoprenylated and supports transformation by an H-Ras:Rap1A chimeric protein.
    Buss JE; Quilliam LA; Kato K; Casey PJ; Solski PA; Wong G; Clark R; McCormick F; Bokoch GM; Der CJ
    Mol Cell Biol; 1991 Mar; 11(3):1523-30. PubMed ID: 1899909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of protein isoprenylation and p21ras membrane association by dehydroepiandrosterone in human colonic adenocarcinoma cells in vitro.
    Schulz S; Nyce JW
    Cancer Res; 1991 Dec; 51(24):6563-7. PubMed ID: 1835900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Farnesol is utilized for protein isoprenylation and the biosynthesis of cholesterol in mammalian cells.
    Crick DC; Andres DA; Waechter CJ
    Biochem Biophys Res Commun; 1995 Jun; 211(2):590-9. PubMed ID: 7794274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. v-K-ras leads to preferential farnesylation of p21(ras) in FRTL-5 cells: multiple interference with the isoprenoid pathway.
    Laezza C; Di Marzo V; Bifulco M
    Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13646-51. PubMed ID: 9811854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transient palmitoylation supports H-Ras membrane binding but only partial biological activity.
    Coats SG; Booden MA; Buss JE
    Biochemistry; 1999 Sep; 38(39):12926-34. PubMed ID: 10504264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Xenopus oocyte germinal-vesicle breakdown induced by [Val12]Ras is inhibited by a cytosol-localized Ras mutant.
    Gibbs JB; Schaber MD; Schofield TL; Scolnick EM; Sigal IS
    Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6630-4. PubMed ID: 2672000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.
    Guerrero S; Casanova I; Farré L; Mazo A; Capellà G; Mangues R
    Cancer Res; 2000 Dec; 60(23):6750-6. PubMed ID: 11118062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The N-ras oncogene is activated in a human medulloblastoma cell line.
    Fults D; Maness PF; Nakamura Y; White R
    Brain Res; 1989 Dec; 503(2):281-7. PubMed ID: 2691018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isoprenoid modification of G25K (Gp), a low molecular mass GTP-binding protein distinct from p21ras.
    Maltese WA; Sheridan KM
    J Biol Chem; 1990 Oct; 265(29):17883-90. PubMed ID: 2120220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts.
    Cuadrado A; Bruder JT; Heidaran MA; App H; Rapp UR; Aaronson SA
    Oncogene; 1993 Sep; 8(9):2443-8. PubMed ID: 8361757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.